Expression of xCT is reportedly up-regulated in GBM [15], and expression of EAAT2 in both tumoral and peri-tumoral tissues has been shown to be downregulated in GBM patients with epilepsy [16]. The gene discussed is SLC1A2; the disease is epilepsy.